Journal of the National Cancer Institute (JNCI) |
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors |
Jan. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) |
Jan. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
SUVmax after (18)fluoro-deoxyglucose positron emission tomography/computed tomography: A tool to define treatment strategies in pancreatic cancer |
Jan. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Annals of oncology |
RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial |
Jan. 18 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma. |
Jan. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Gut |
Endoscopic resection of high-risk T1 colorectal carcinoma prior to surgical resection has no adverse effect on long-term outcomes. |
fév. 18 |
4 ♥ |
Endoscopie/Imagerie |
Journal of clinical oncology (JCO) |
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study. |
fév. 18 |
3 ♥ |
Cancer colorectal (CCR) |
Clinical Gastroenterology and Hepatology |
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission |
fév. 18 |
3 ♥ |
MICI |
Gut |
Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. |
fév. 18 |
4 ♥ |
Endoscopie - Imagerie, Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database. |
fév. 18 |
3 ♥ |
Carcinome hépatocellulaire (CHC) |
British journal of Cancer |
Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study. |
fév. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
Gastrointestinal lymphomas: French Intergroup clinical practice recommendations for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFH) |
fév. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma |
fév. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
Clinical outcome after biliary drainage for metastatic colorectal cancer: Survival analysis and prognostic factors |
fév. 18 |
1 ♥ |
Cancer colorectal (CCR) |
Digestive and Liver Disease |
Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41–BEVANEC randomized phase II study |
fév. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
The Lancet |
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. |
mar. 18 |
2 ♥ |
Foie |
Diseases of the Colon & Rectum |
Challenges in Transition of Care for Patients With Anorectal Malformations: A Systematic Review and Recommendations for Comprehensive Care. |
mar. 18 |
4 ♥ |
Colo-proctologie |
Journal of clinical oncology (JCO) |
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. |
mar. 18 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9). |
mar. 18 |
4 ♥ |
Cancer colorectal (CCR) |
Clinical Gastroenterology and Hepatology |
Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. |
mar. 18 |
3 ♥ |
MICI |
Journal of clinical oncology (JCO) |
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma. |
mar. 18 |
4 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of the National Cancer Institute (JNCI) |
Analysis of Postoperative Recurrence in Stage I–III Midgut Neuroendocrine Tumors |
mar. 18 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology). |
mar. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
No effect of comorbidities on the association between social deprivation and geographical access to the reference care center in the management of colon cancer |
mar. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Digestive and Liver Disease |
Clinical outcome of portal vein thrombosis in patients with digestive cancers: A large AGEO multicenter study |
mar. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |